Acacia Biotech Profile
Key Indicators
- Authorised Capital ₹ 1.01 Cr
as on 17-11-2024
- Paid Up Capital ₹ 0.75 M
as on 17-11-2024
- Company Age 19 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 2.90 Cr
as on 17-11-2024
- Revenue -59.58%
(FY 2023)
- Profit -7389.08%
(FY 2023)
- Ebitda -183.66%
(FY 2023)
- Net Worth -5.75%
(FY 2023)
- Total Assets -11.51%
(FY 2023)
About Acacia Biotech
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.01 Cr and a paid-up capital of Rs 0.75 M.
The company currently has active open charges totaling ₹2.90 Cr.
Jyoti Agrawal, Arun Tulsiyan, Dinesh Patel, and One other member serve as directors at the Company.
- CIN/LLPIN
U24230GJ2005PLC046251
- Company No.
046251
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
15 Jun 2005
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Acacia Biotech?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jyoti Agrawal  | Whole-Time Director | 13-Jun-2019 | Current |
| Arun Tulsiyan | Director | 02-Feb-2006 | Current |
| Dinesh Patel | Director | 23-Feb-2012 | Current |
| Prabhat Agrawal | Whole-Time Director | 13-Jun-2019 | Current |
Financial Performance and Corporate Structure Insights of Acacia Biotech.
Acacia Biotech Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 59.58% decrease. The company also saw a substantial fall in profitability, with a 7389.08% decrease in profit. The company's net worth dipped by a decrease of 5.75%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Acacia Biotech?
In 2023, Acacia Biotech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Central Bank Of India Creation Date: 22 Aug 2006 | ₹2.90 Cr | Open |
How Many Employees Work at Acacia Biotech?
Acacia Biotech has a workforce of 9 employees as of Aug 31, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Acacia Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Acacia Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
